Masterson Nola E
Transactions
50
Companies
3
Filings
12
CIK
0001305231
Recent Transactions
- Award
- Award
- Award
- Award
- Award
- Disposition to Issuer
Nonstatutory Stock Option to Purchase Common Stock
2024-06-05−1,902→ 0 total - Disposition to Issuer
Nonstatutory Stock Option to Purchase Common Stock
2024-06-05−4,333→ 0 total - Disposition to Issuer
Nonstatutory Stock Option to Purchase Common Stock
2024-06-05−2,632→ 0 total - Disposition to Issuer
Nonstatutory Stock Option to Purchase Common Stock
2024-06-05−3,626→ 0 total - Disposition to Issuer
- Award
Nonstatutory Stock Option to Purchase Common Stock
2023-06-12+21,756→ 21,756 total - Purchase
- Award
Nonstatutory Stock Option to Purchase Common Stock
2022-12-16+4,244→ 4,244 total - Award
Nonstatutory Stock Option to Purchase Common Stock
2022-07-28+15,797→ 15,797 total - Award
Nonstatutory Stock Option to Purchase Common Stock
2022-07-28+15,797→ 15,797 total - Award
Nonstatutory Stock Option to Purchase Common Stock
2021-10-21+26,000→ 26,000 total - Award
Nonstatutory Stock Option to Purchase Common Stock
2021-10-12+11,416→ 11,416 total - Purchase
- Purchase
- Tax Payment
- Exercise/Conversion
- Exercise/Conversion
- Tax Payment
- Exercise/Conversion
- Exercise/Conversion
- Exercise/Conversion
- Exercise/Conversion
- Award
- Award
- Disposition to Issuer
- Disposition to Issuer
- Disposition from Tender
- Award
- Award
- Award
- Sale
- Award
- Award
- Award
- Award
- Award
- Purchase
- Award
- Exercise/Conversion
- Tax Payment
- Exercise/Conversion
- Exercise/Conversion
- Exercise/Conversion
- Exercise/Conversion
- Exercise/Conversion
Companies
3Recent Filings
12- 4
Masterson Nola E
Jan 3, 2025
- 4
Masterson Nola E
Jun 13, 2024
- 4
Masterson Nola E
Jun 6, 2024
- 4
Masterson Nola E
Jun 14, 2023
- 4
Masterson Nola E
Dec 21, 2022
- 4
Masterson Nola E
Dec 20, 2022
- 4/A
Masterson Nola E
Dec 8, 2022
- 4
Masterson Nola E
Aug 1, 2022
- 4
Masterson Nola E
Oct 25, 2021
- 4
Masterson Nola E
Oct 15, 2021
- 4
Masterson Nola E
Jun 4, 2021
- 4
Masterson Nola E
Dec 1, 2020
Address
C/O GENEREX BIOTECHNOLOGY CORPORATION 33 HARBOUR SQUARE, SUITE 202
TORONTO, A6, M5J 2G2